|
Volumn 140, Issue 4, 2005, Pages 585.e1-585.e15
|
Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase®) for the management of vitreous hemorrhage
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYALURONIDASE;
ADULT;
AGED;
ANAMNESIS;
ARTICLE;
B SCAN;
BLINDNESS;
CATARACT;
CHEMOSIS;
CLINICAL EXAMINATION;
CLINICAL TRIAL;
CONJUNCTIVAL HYPEREMIA;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SCREENING;
ENDOPHTHALMITIS;
EYE DISEASE;
EYE IRRITATION;
EYE PAIN;
EYE PHOTOGRAPHY;
FEMALE;
HUMAN;
HYPOPYON;
INTRAOCULAR PRESSURE;
INTRAOCULAR PRESSURE ABNORMALITY;
IRIS RUBEOSIS;
IRITIS;
LACRIMAL GLAND DISEASE;
LACRIMATION;
MAJOR CLINICAL STUDY;
MALE;
OPHTHALMOSCOPY;
PHASE 3 CLINICAL TRIAL;
PHOTOPHOBIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RETINA DETACHMENT;
RETINA MACULA EDEMA;
SLIT LAMP;
VISUAL ACUITY;
VITREOUS HEMORRHAGE;
|
EID: 26844577329
PISSN: 00029394
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ajo.2005.06.022 Document Type: Article |
Times cited : (75)
|
References (14)
|